DE69522578D1 - Glial neurotropher faktor als nervenschutzmittel - Google Patents

Glial neurotropher faktor als nervenschutzmittel

Info

Publication number
DE69522578D1
DE69522578D1 DE69522578T DE69522578T DE69522578D1 DE 69522578 D1 DE69522578 D1 DE 69522578D1 DE 69522578 T DE69522578 T DE 69522578T DE 69522578 T DE69522578 T DE 69522578T DE 69522578 D1 DE69522578 D1 DE 69522578D1
Authority
DE
Germany
Prior art keywords
glial
factor
neurotropher
protection agent
gdnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69522578T
Other languages
English (en)
Other versions
DE69522578T2 (de
Inventor
David Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DE69522578D1 publication Critical patent/DE69522578D1/de
Application granted granted Critical
Publication of DE69522578T2 publication Critical patent/DE69522578T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69522578T 1994-11-15 1995-11-13 Glial neurotropher faktor als nervenschutzmittel Expired - Fee Related DE69522578T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34082194A 1994-11-15 1994-11-15
PCT/IB1995/001004 WO1996014861A1 (en) 1994-11-15 1995-11-13 Glial derived neurotrophic factor as a neuroprotective agent

Publications (2)

Publication Number Publication Date
DE69522578D1 true DE69522578D1 (de) 2001-10-11
DE69522578T2 DE69522578T2 (de) 2002-07-11

Family

ID=23335068

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69522578T Expired - Fee Related DE69522578T2 (de) 1994-11-15 1995-11-13 Glial neurotropher faktor als nervenschutzmittel

Country Status (13)

Country Link
US (1) US5733875A (de)
EP (1) EP0792160B1 (de)
JP (1) JPH10508839A (de)
AT (1) ATE205088T1 (de)
AU (1) AU691349B2 (de)
CA (1) CA2204911C (de)
DE (1) DE69522578T2 (de)
DK (1) DK0792160T3 (de)
ES (1) ES2159647T3 (de)
IL (1) IL115966A (de)
PT (1) PT792160E (de)
WO (1) WO1996014861A1 (de)
ZA (1) ZA959714B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184200B1 (en) * 1995-09-28 2001-02-06 Amgen Inc. Truncated glial cell line-derived neurotrophic factor
US5641750A (en) * 1995-11-29 1997-06-24 Amgen Inc. Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
AU1121997A (en) * 1995-11-29 1997-06-19 Amgen, Inc. Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product
US5641749A (en) * 1995-11-29 1997-06-24 Amgen Inc. Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
US6677135B1 (en) 1996-05-08 2004-01-13 Biogen, Inc. Ret ligand (RetL) for stimulating neutral and renal growth
TR199901734T2 (xx) 1996-11-15 2000-01-21 Genentech, Inc. N�rotrofinlerin ar�t�lmas�.
US6277820B1 (en) 1998-04-09 2001-08-21 Genentech, Inc. Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells
DE60002496T2 (de) * 1999-10-29 2004-03-25 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Verwendung von gdnf für behandlung von hornhautdefekten
US20040197900A1 (en) * 2003-04-04 2004-10-07 Arnon Rosenthal Foggy
HUE030903T2 (en) 2006-04-25 2017-06-28 Univ California Administration of growth factors for the treatment of CNS disorders
EP2023949A4 (de) * 2006-04-26 2009-08-26 Univ California Zusammensetzungen und verfahren für konvektionsverstärkte freisetzung von neurotherapeutika mit hohem molekulargewicht
WO2009128057A2 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
EP2968462B1 (de) 2013-03-15 2020-12-23 The Jackson Laboratory Verfahren zur förderung von wundheilung und haarwachstum
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
CA3043179A1 (en) 2016-11-10 2018-05-17 Keros Therapeutics, Inc. Gdnf fusion polypeptides and methods of use thereof
EP3973979A1 (de) * 2020-09-25 2022-03-30 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth Tight-junction (zonulae occludentes)-protein zur verwendung in der behandlung oder vorbeugung einer neurologischen störung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006116A1 (en) * 1991-09-20 1993-04-01 Syntex-Synergen Neuroscience Joint Venture Glial derived neurotrophic factor
FR2717824B1 (fr) * 1994-03-25 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.

Also Published As

Publication number Publication date
CA2204911A1 (en) 1996-05-23
CA2204911C (en) 2002-07-23
WO1996014861A1 (en) 1996-05-23
EP0792160A1 (de) 1997-09-03
AU691349B2 (en) 1998-05-14
ES2159647T3 (es) 2001-10-16
JPH10508839A (ja) 1998-09-02
ATE205088T1 (de) 2001-09-15
DK0792160T3 (da) 2001-11-19
AU3752895A (en) 1996-06-06
IL115966A (en) 1999-11-30
US5733875A (en) 1998-03-31
IL115966A0 (en) 1996-01-31
ZA959714B (en) 1997-10-15
PT792160E (pt) 2002-02-28
DE69522578T2 (de) 2002-07-11
EP0792160B1 (de) 2001-09-05

Similar Documents

Publication Publication Date Title
DE69522578D1 (de) Glial neurotropher faktor als nervenschutzmittel
EP1674107B8 (de) Verwendung von Daptomycin
PL316080A1 (en) Pharmaceutic composition for sublingual or intrabuccal administration
AP2001002079A0 (en) Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents.
FI935847A (fi) L-DOPA-esterikoostumukset
ZA941542B (en) Heterocyclic compounds their use and preparation
EP0830369A4 (de) Nor-pregnane zur induzierung hypothalamischer effekte
ATE187641T1 (de) Verfahren zum bekämpfen der pneumocystis carinii pneumonie und dafür verwendbare verbindungen
HUP0302635A2 (hu) Valpronsav foszfolipidszármazékai és ezek keveréke
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
BG103842A (en) 5,7-disubstituted 4-aminopyrido [2,3-d]pyrimidine compounds and their application as adenosinekinase inhibitors
CA2282279A1 (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
UA41285C2 (uk) Креатин фосфат і його фармацевтично прийнятні солі для лікування пухлин та фармацевтична композиція, що має протипухлинну активність
MX9707596A (es) Benzamidas, el uso de las mismas, composiciones que las contienen, para el tratamiento del transtorno neurodegenerativo, y procedimiento para la preparacion del mismo.
UA66751C2 (en) Benzamides as medicament for treatment of neurodegenerative state, a method for the preparation thereof (variants), pharnaceutical composition for treatment of neurodegenerative states and a method for treatment
AU2287197A (en) Heterocyclic compounds and their preparation and use
WO1994016705A3 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
WO1997019669A3 (en) Heterocyclic compounds and their use
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee